Overview

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Nab-paclitaxel Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Status:
Not yet recruiting
Trial end date:
2028-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this research is to see if combining gemcitabine, cisplatin and nab-paclitaxel chemotherapy treatments with a direct tumor therapy called Yittrium-90, will work better together to shrink the tumor and control cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Inova Health Care Services